Burns

Published on 27/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1255 times

Chapter 73 Burns

The last half of the twentieth century witnessed a sustained improvement in the survival of patients suffering thermal injury. Arguably, the single most important development has been the establishment of centralised burn care which made possible advances in fluid resuscitation, life support techniques and the prevention of infection. With optimal care, children and young adults with burns of more than 80% of total body surface area (TBSA) now stand a reasonable chance of survival.1

Improvements in survival have gradually led to a shift of emphasis in burn care towards qualitative aspects, such as rehabilitation and quality of life. The complexity of care has led to the concept of the multidisciplinary burn team, in which all aspects of care are coordinated in an integrated approach to clinical management.1

PATHOPHYSIOLOGY

LOCAL EFFECTS

Thermal injury produces complex local and systemic responses. The local inflammatory response results in vasodilatation and an increase in vascular permeability. The changes are immediate and combine to produce extravasation of fluid and plasma protein at the site of injury. In extensive burns, oedema becomes generalised. The greatest rate of oedema formation occurs in the first few hours, but further extravasation occurs up to 24 hours post burn.2 The total amount of oedema formed depends on the extent of injury and the volume and rate of fluid administration. Without fluid replacement, hypovolaemic shock occurs, limiting the extent of extravasation. On the other hand, excessive fluid administration will produce excessive oedema. By 24 hours post burn, oedema formation is largely complete and vascular integrity restored.

The process of deepening of the burn wound beyond the area of heat necrosis following injury is at least partly due to microvascular stasis. Events occurring within minutes and hours of injury that contribute to stasis include microthrombus formation, neutrophil adherence, fibrin deposition and endothelial swelling. Diverse agents, including antioxidants and anti-inflammatory drugs, have been shown to attenuate this process in experimental settings, but none is yet established in clinical practice. Empirically, it is assumed that maintenance of good tissue oxygenation, avoidance of overresuscitation and prevention of wound dehydration all contribute to wound healing by preventing undue extension of necrosis in the wound bed.

PHARMACOLOGICAL EFFECTS

The pharmacokinetics and pharmacodynamics of many drugs are markedly altered in burn patients. During the first 24 hours, when the cardiac output is depressed, absorption and distribution of administered drugs are delayed. Thereafter, increased cardiac output leads to accelerated drug absorption and distribution, while oedema fluid acts as an ill-defined third space. At the same time, renal blood flow and creatinine clearance are increased, particularly in younger patients. Drugs excreted via this route, such as the quinolone and aminoglycoside antibiotics, may therefore fail to reach effective levels at conventional dosages.9 On the other hand, toxic levels may ensue if renal failure supervenes. If possible, therefore, antibiotic administration should be guided by measurement of plasma concentrations.

Serum albumin levels are low in burn patients, and drugs bound to this protein, including some benzodiazepines, will show increased bioavailability. On the other hand, α1-glycoprotein levels, which bind fentanyl, are increased. Detoxification via redox pathways, such as cytochrome P-450, is depressed, lengthening the half-life of drugs such as diazepam.10 Accumulation of benzodiazepine derivatives may be increased.

The pharmacodynamics of muscle relaxants are significantly altered due to an increase in peri-junctional acetylcholine receptors.11 Patients become relatively insensitive to non-depolarising agents, while administration of succinylcholine may give rise to excessive release of potassium, and cardiac arrest.

The burn wound is a significant route of drug absorption as well as drug loss. For example, the topical sulfonamide agent, mafenide, may cause metabolic acidosis through inhibition of renal carbonic anhydrase; deafness has been reported following the topical use of gentamicin.

CLINICAL MANAGEMENT

FIRST AID

Immediate aid comprises stopping the burn process, followed by the removal of clothing and cooling the wound, preferably with tepid, running water, for 10–20 minutes. This provides pain relief and may prevent deepening of the wound.12 Hypothermia should be avoided. Oxygen should be given, if available, and patients with burns to head and neck should be kept in a semi-upright position. Burn injury can only be assessed properly in hospital conditions, and priority should be given to early evacuation of the victim.

FLUID THERAPY: 0–24 HOURS

Fluid therapy is required for injuries exceeding 15% of body surface area (10% in children and the elderly), preferably via a wide-bore peripheral i.v. cannula (preferably not in a burned area). The aim is to provide sufficient salt and water to preserve normal organ function, while minimising oedema formation. Excessive fluid administration increases the risk of circulatory overload in the days following the resuscitation period. Potentially fatal complications of excessive fluid administration include the abdominal compartment syndrome in adults13 and the occurrence of cerebral oedema in children.14 An increasing tendency in recent years to overresuscitate burn patients has been signalled.15,16 In contrast to other traumatic injuries, burn hypovolaemia is gradual, obligatory and predictable. Aggressive fluid administration will not restore the circulating volume17 and in the absence of frank shock, bolus fluids should not be given.

Various resuscitation formulae have been published in the past to guide initial fluid therapy. These formulae are entirely experience-based and many are of historical interest only, but all comprise a fluid intake of 2–4 ml/kg body weight per % burn in 24 hours, and a sodium intake of approximately 0.5 mmol/kg per % burn.18 These findings have led some to employ resuscitation regimens based on the administration of hypertonic sodium solutions, which require a smaller volume of fluid. However, the solute load may be excessive, requiring extra water administration in subsequent days, with an increased risk of fluid overload. The use of isotonic saline solutions is therefore preferred by those without experience of burns resuscitation.

The most widely used resuscitation formula for adults is based on the Parkland Formula, which has been adopted by major training programmes, such as the Advanced Trauma Life Support and the Emergency Medicine for Severe Burns:

image

The formula thus incorporates a faster rate of administration if initial treatment has been delayed.

Children require extra fluid to compensate for basal needs. For children under 30 kg, the resuscitation formula of Carvajal19 is useful:

image

where TBSA is the total body surface area (m2) and TBSAB is total body surface area burned (m2). Again half of the calculated amount is given in the first 8 hours.

These formulae are to be regarded as guidelines only. The actual amount of fluid given depends on the clinical condition and the actual amount of fluid administered can vary widely from that predicted. Adequacy of resuscitation is monitored by vital signs and a targeted urine output of 0.5–1 ml/kg per hour in adults and 1–2 ml/kg per hour in children. Other indicators include warm extremities and return of gut peristalsis. Fluid intake may be adjusted to maintain urine output at the desired range. Requirements are increased in the presence of mechanical ventilation, additional traumatic injury and dehydration (e.g. fire-fighters).

Invasive monitoring is not essential in uncomplicated burns and the results may be misleading, as central pressures are invariably low. Hypoalbuminaemia develops rapidly and may be extreme. The extent to which burn patients will tolerate hypoalbuminaemia is unknown and clinical studies into best practice are awaited. In our unit at present, albumin is given to maintain serum albumin above 15 g/l, commencing 12 hours post burn when capillary integrity has been largely restored.

Thirst is common, but unrestricted oral fluids will increase oedema formation. Controlled quantities of nutritional liquids are recommended to protect gut integrity.20 In patients with extensive injuries, tube feeding at a low rate can be commenced within a few hours of injury.

WOUND HEALING

Treatment of extensive, full-thickness burn wounds by early excision and grafting has been firmly linked to survival.29 Wound excision should be completed within the first week, before bacterial colonisation and neovascular infiltration of the wound bed develop. These operations are therefore urgent. Successfully grafted wounds will heal within 5 weeks, reducing the time available for bacterial infection to develop, and shortening the period of physiological disturbance. Wounds covered with widely meshed autografts lose large amounts of fluid, unless protected by a semipermeable layer, such as allograft skin. Autograft donor sites are a further source of fluid loss.

For wounds treated conservatively, the main effort is devoted to the prevention of infection. Topical antimicrobial agents are commonly used, but may have potential side-effects (Table 73.1). These compounds change the appearance of the wound and should never be applied until expert wound inspection is complete. A number of biosynthetic materials are currently available, which are designed to improve cosmetic and functional outcome. Despite the use of antiseptic dressings or biosynthetic coverings there is still a risk of microbial infection developing and unexplained signs of sepsis may necessitate urgent wound revision.

Table 73.1 Commonly used topical antimicrobial agents

Agent Comments
Silver sulfadiazine (SSD) The most widely used agent with broad spectrum cover. Hypersensitivity (rarely) and transient leucopenia have been reported
Cerium nitrate 0.5% Often added to SSD, and forms a stable eschar. It is reported to bind ‘burn toxins’. Methaemoglobinaemia has been reported
Silver nitrate 0.5% Applied as a soak, and is especially effective against Pseudomonas. However, it may increase sodium loss, and potentially can cause methaemoglobinaemia
Mafenide acetate 5–10% Effective but short-lived antimicrobial, requiring repeated application. It has good penetration, and its side-effects (pain and metabolic acidosis) are less evident with 5% solution
Chlorhexidine Aqueous solution (0.2%) or 1% gel provides broad spectrum cover, but is rapidly inactivated, and may cause local pain, and rarely causes hypersensitivity
Nitrofurazone In polyethylene glycol (PEG) solution it is effective against S. aureus, but resistance develops early. Side-effects include hypersensitivity (common), hyperosmolarity, and renal failure due to PEG absorption has been reported
Povidone iodine In PEG solution provides broad spectrum cover, but is rapidly inactivated. It prevents wound maceration. Side-effects include occasional hypersensitivity, renal dysfunction due to excessive PEG, metabolic acidosis and rarely dysfunction
Antibiotics Have been used in solutions, creams, gels and sprays, but selection and development of resistant strains is inevitable, with a risk of systemic toxicity through absorption. Their usage is generally discouraged

PREVENTION OF WOUND INFECTION

Bacterial infection is still the most common cause of death in burns. Depression of the immune system is well documented.30 At the same time, the burn wound presents a favourable medium for bacterial growth.

PATIENT ISOLATION

In an effort to reduce wound colonisation and contamination from cross-infection, barrier nursing of patients with extensive injuries is mandatory. The importance of isolation measures has been stressed,31 but a significant proportion of patients still become colonised by micro-organisms from endogenous reservoirs, which cannot be controlled by barrier nursing alone.32,33 Positive experiences have been reported with selective decontamination of the digestive tract,8,34 but large scale prospective trials have not been performed.

THE GASTROINTESTINAL TRACT

Loss of gut integrity following burn injury has been well demonstrated.35 In addition to reactive damage following reperfusion of the ischaemic gut, mediators derived from the burn wound itself may also be involved.36 Clinical strategies aimed at protecting the gastrointestinal tract include optimal fluid therapy during the first hours following injury to prevent mesenteric hypoperfusion, and the institution of early enteral nutrition, which can be safely commenced within a few hours of injury.20 Diets enriched with glutamine may contribute to the maintenance of gut integrity.26,37 Whatever the merits of each approach, all are secondary to the maintenance of effective hygienic policies in all aspects of patient care.

INHALATION INJURY

The term inhalation injury includes three distinct types of injury which often, but not always, occur together. The presence of inhalation injury may increase resuscitation fluid requirements in patients with extensive cutaneous burns.

EFFECTS OF SMOKE ON THE RESPIRATORY SYSTEM

Many of the chemicals that are contained in smoke are highly reactive and produce damage to the tracheobronchial tree. Detachment of epithelial cells and the development of tracheobronchial oedema cause airway narrowing and cast formation. Small airway closure leads to hypoxaemia and respiratory failure. Later, bronchorrhoea and mucosal sloughing may cause atelectasis and provide a focus for infection. In the absence of a cutaneous injury the clinical course is usually benign. However, the presence of an extensive skin burn increases the likelihood of acute respiratory distress syndrome (ARDS); respiratory infection may follow.

INHALATION OF TOXIC GASES

Of the many toxic compounds38 in smoke (Table 73.2), carbon monoxide (CO) deserves special mention. The affinity of CO for haemoglobin is 240 times that of oxygen. The loss of oxygen transport capacity is dependent on the concentration of inhaled CO and the duration of exposure. In addition, CO binds to cytochrome systems, inhibiting cellular oxidative processes. The half-life of COHb is 4 hours when breathing air, compared with 45 minutes when breathing 100% oxygen.

Table 73.2 Common inhaled toxic gases

Gas Source Effect
Carbon monoxide Organic matter Tissue hypoxia, lipid peroxidation
Carbon dioxide Organic matter Narcosis, tachycardia, hypertension
Nitrogen dioxide Wallpaper, wood Bronchial irritation, dizziness, pulmonary oedema
Hydrogen chloride Plastics Severe mucosal irritation
Hydrogen cyanide Wood, silk, nylons, polyurethane Headache, coma, acidosis
Benzene Petrol, plastics Mucosal irritation, coma
Ammonia Nylon Mucosal damage, extensive lung injury
Aldehyde Wood, cotton, paper Mucosal irritation

REFERENCES

1 Herndon DN, Blakeney PE. Teamwork for total burn care: achievements, directions and hopes. In: Herndon DN, editor. Total Burn Care. 2nd edn. London: WB Saunders; 2002:11-15.

2 Demling RH, Mazess RB, Witt RM. The study of burn wound edema using dichromatic absorptiometry. J Trauma. 1978;18:124-128.

3 Cioffi WG, De Meules JE, Gamelli RL. The effects of burn injury and fluid resuscitation on cardiac function in vitro. J Trauma. 1986;26:638-643.

4 Cioffi WG, Vaughan GM, Heironimus JD. Disassociation of blood volume and flow in regulation of salt and water balance in burn patients. Ann Surg. 1991;214:213-219.

5 Wilmore DW, Mason AD, Johnson DW. Effect of ambient temperature on heat production and heat loss in burn patients. J Appl Physiol. 1975;38:593-597.

6 Caldwell FT, Bowser GH, Crabtree JH. The effects of occlusive dressings on the energy expenditure of severely burned children. Ann Surg. 1981;193:579-591.

7 Waymack JP. Antibiotics and the post-burn hypermetabolic response. J Trauma. 1990;30:S30-35.

8 Mackie DP, van Hertum WAJ, Schumburg T. Prevention of infection in burns: preliminary experience with selective decontamination of the digestive tract in patients with extensive injuries. J Trauma. 1992;32:570-575.

9 Alexander D, Richard K, Morris S. Application of newer antibiotic concepts in the use of ciprofloxacin for treatment of infections in the burn patient. J Burn Care Rehab. 2001;22:S137.

10 Martyn JAJ, Greenblatt GS, Quinby WC. Diazepam kinetics following burn injury. Anesth Analg. 1983;62:293-297.

11 Martyn JAJ, Fukushima Y, Chon JY, et al. Muscle relaxants in burns, trauma, and critical illness. Int Anesthesiol Clin. 2006;44:123-143.

12 Davies JWL. Prompt cooling of the burned area: a review of the benefits and the effector mechanisms. Burns. 1982;9:1-6.

13 Ivy ME, Atweh NA, Palmer J. Intra-abdominal hypertension and abdominal compartment syndrome in burn patients. J Trauma. 2000;49:387-391.

14 Prekop R, Bardosova G, Simko S. Brain oedema in burned children. Acta Chir Plast. 1984;26:184-192.

15 Pruitt BAJr. Protection from excessive resuscitation: ‘pushing the pendulum back’. J Trauma. 2000;49:567-568.

16 Friedrich JB, Sullivan SR, Engrav LH. Is supra-Baxter resuscitation in burns patients a new phenomenon? Burns. 2004;39:583-590.

17 Holm C, Mayr M, Tegeler J. A clinical randomised study on the effects of invasive monitoring on burn shock resuscitation. Burns. 2004;30:798-807.

18 Settle JAD. Principles of replacement fluid therapy. In: Settle JAD, editor. Principles and Practice of Burns Management. London: Churchill Livingstone; 1996:217-222.

19 Carvajal HF. A physiologic approach to fluid therapy in severely burned children. Surg Gynecol Obstet. 1980;150:379-384.

20 Alexander JW, Gottschlich MM. Nutritional immunomodulation in burn patients. Crit Care Med. 1990;18:S149-153.

21 Choinière M, Melzak R, Rondeau J. The pain of burns: characteristics and correlates. J Trauma. 1989;29:1531-1539.

22 Taal LA, Faber AW, van Loey NEE. The abbreviated burn-specific anxiety scale: a multi-centre study. Burns. 1999;25:493-497.

23 Miller AC, Hickman LC, Lemasters GK. A distraction technique for control of burn pain. J Burn Care Rehabil. 1992;13:576-580.

24 Berger MM, Cavadini C, Chiolero R. Influence of large intakes of trace elements on recovery after burns. Nutrition. 1994;10:327-334.

25 Wolfe RR. Caloric requirements of the burned patients. J Trauma. 1981;21:712-714.

26 Windle EM. Glutamine supplementation in critical illness: evidence, recommendations, and implications for clinical practice in burn care. J Burn Care Rehab. 2006;27:764-772.

27 Wolf S, Edelman L, Kemalyan N. Effects of oxandrolone on outcome measures in the severely burned: a multicenter prospective double-blind trial. J Burn Care Res. 2006;27:131-141.

28 Pereira CT, Murphy KD, Herndon DN. Altering metabolism. J Burn Care Rehabil. 2005;26:194-199.

29 Muller MJ, Ralston D, Herndon DN. Operative wound management. In: Herndon DN, editor. Total Burn Care. 2nd edn. London: WB Saunders; 2002:170-182.

30 Abraham E. Physiologic stress and cellular ischemia: relationship to immunosuppression and susceptibility to sepsis. Crit Care Med. 1991;19:613-618.

31 McManus AT, Mason WF, McManus WF. A decade of reduced Gram negative infections and mortality. Abstracts, 5th European Burns Association Congress. 1992, M2.

32 Burke JF, Quimby WC, Bondoc CC. The contribution of a bacterially isolated environment to the prevention of infection in seriously burned patients. Ann Surg. 1977;186:377-387.

33 Lee JJ, Marvin JA, Heimbach DM. Infection control in a burns centre. J Burn Care Rehabil. 1990;11:575-580.

34 Manson WL, Klasen HJ, Sauer EW. Selective intestinal decontamination for prevention of wound colonization in severely burned patients: a retrospective analysis. Burns. 1992;18:98-102.

35 Deitch EA. Intestinal permeability is increased in burn patients shortly after injury. Surgery. 1990;107:411-416.

36 Trop M, Schiffrin EJ, Carter EA. Effect of platelet activating factor on reticulo-endothelial system function. Burns. 1991;17:193-197.

37 Peng X, Yan H, You Z, et al. Glutamine granule-supplemented enteral nutrition maintains immunological function in severely burned patients. Burns. 2006;32:589-593.

38 Prien T, Traber DL. Toxic smoke compounds and inhalation injury – a review. Burns. 1988;14:451-460.

39 Purser DA, Grimshaw P, Berril KR. Intoxication by cyanide in fires: a study in monkeys using polyacrylonitrile. Arch Environmental Health. 1984;39:394-400.